Study Reveals ER-Phagy's Role in Aging and Disease
Researchers have identified ER-phagy as a key process in cellular aging, offering potential targets for age-related disease therapies.
Recent research has uncovered that cells actively remodel the endoplasmic reticulum (ER) through a process called ER-phagy as they age. This selective degradation of ER regions may contribute to age-related conditions such as neurodegenerative disorders and metabolic diseases.
The study, published in Nature Cell Biology, highlights that ER-phagy leads to a reduction in 'rough' ER, associated with protein production, while the 'tubular' ER, linked to lipid synthesis, remains relatively unchanged. This shift aligns with common aging features like decreased protein maintenance and increased fat accumulation.
Assistant Professor Kris Burkewitz, leading the research, emphasized the importance of cellular organization in aging:
"Where many prior studies have documented how the levels of different cellular machineries change with age, we are focusing instead on how aging affects the way that cells house and organize these machineries within their complex inner architectures."
The findings suggest that targeting ER-phagy could be a promising avenue for developing therapies aimed at mitigating age-related diseases.